Painting Genes in Parallel

Courtesy of Tecan Group Knowledge of the tissues and cells that express particular genes is key to understanding gene function. In situ hybridization (ISH), a popular method for deciphering gene expression, is a slow, labor-intensive, error-prone operation that limits parallel investigation of multiple genes and tissues to what may be carried out quickly by hand. These attributes essentially preclude slide-staining efforts from the high-throughput analyses that are so critical to functional ge

Written byAngelo DePalma
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Knowledge of the tissues and cells that express particular genes is key to understanding gene function. In situ hybridization (ISH), a popular method for deciphering gene expression, is a slow, labor-intensive, error-prone operation that limits parallel investigation of multiple genes and tissues to what may be carried out quickly by hand. These attributes essentially preclude slide-staining efforts from the high-throughput analyses that are so critical to functional genomics research. But a new system from Tecan Group, Männedorf, Switzerland, could change all that.

Based on an established pipetting robot platform, GenePaint--invented by Gregor Eichele of the Max Planck Institute of Experimental Endocrinology, Hannover, Germany--delivers high-throughput performance for ISH, fluorescence ISH (FISH), and immunohistochemistry. The system's automated flexibility eliminates 80% of the manual steps of conventional ISH by performing all fixing, staining, washing, and hybridization operations in a temperature-controlled environment. It also integrates specialized reagent kits familiar to molecular biologists (for example, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies